Skip to Content
Merck
CN
  • Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Journal of child and adolescent psychopharmacology (2012-10-23)
Presenters Ornella Potter, Nadyah John, Discussant Barbara J Coffey
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Guanfacine hydrochloride, ≥98% (HPLC)